4.5 Article

Role of Lipid Blooming and Crystallite Size in the Performance of Highly Soluble Drug-Loaded Microcapsules

期刊

JOURNAL OF PHARMACEUTICAL SCIENCES
卷 104, 期 12, 页码 4257-4265

出版社

WILEY-BLACKWELL
DOI: 10.1002/jps.24660

关键词

crystal growth; excipients; lipids; microencapsulation; dissolution; crystal structure; polymorphism; solid state

资金

  1. Austrian COMET Program by the Austrian Federal Ministry of Transport, Innovation and Technology (BMVIT)
  2. Austrian Federal Ministry of Economy, Family and Youth (BMWFJ)
  3. State of Styria (Styrian Funding Agency SFG)
  4. Hermes Arzneimittel GmbH
  5. Cremer Oleo GmbH and Company KG

向作者/读者索取更多资源

Hot-melt coating is of growing interest, because it does not require solvents, resulting in reduced process times and costs. However, excipients for this technology are mainly triacylglycerides (TAGs) or their derivatives, which exhibit polymorphism, surface disruption, and complex crystallite networks, affecting the release profile of produced microcapsules. In this work, anhydrous citric acid crystals were coated with molten tristearin using conventional inlet air temperatures (microcapsules A) and temperatures above the melting point of -form (microcapsules B). Additionally, microcapsules A were tempered to achieve polymorphic stability (microcapsules AB). The product yield and coating efficacy were above 90% and 97%, respectively, demonstrating the feasibility and efficacy of the process. Small angle X-ray scattering analysis confirmed that the tristearin shell of microcapsules B is in the -form with a larger average crystallite size than microcapsules A and AB. Scanning electron microscopy images revealed a nonbloomed surface of microcapsules B. We showed that blooming does not play a critical role in the drug release, but the apparent diffusion coefficient of drug is dramatically reduced by increasing TAGs crystallite size and resulting tortuosity. This work brings new insights on the micrometric properties of solid lipid dosage forms, being an important step to prevent the overuse of excipients with unknown toxicity. (C) 2015 Wiley Periodicals, Inc. and the American Pharmacists Association

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据